<DOC>
	<DOCNO>NCT02450695</DOCNO>
	<brief_summary>This study evaluate effectiveness rTMS potential treatment refractory OCD randomize , crossover design .</brief_summary>
	<brief_title>rTMS Treatment Refractory Obsessive-Compulsive Disorder</brief_title>
	<detailed_description>The study minimum 7 week long . In first treatment phase ( three week ) , participant randomly assign one two treatment condition : active rTMS sham rTMS . The `` sham '' rTMS inactive form treatment experience session similar active rTMS session , medical value . During 3 week , attend session day 5 day per week Mood Disorders Clinic locate St. Joseph 's Healthcare . Each session hour long total 15 visit first 3 week . After every 5 session ask complete follow self-report questionnaire : Baratt Impulsiveness Scale , Hamilton Anxiety Rating Scale Hamilton Depression Rating Scale . The clinician-rated : Clinical Global Impression Scale Yale Brown Obsessive Compulsive Scales also complete . The two treatment phase separate flexible wash-out minimum one week participant attend visit . After , begin second treatment phase ( three week ) treatment condition previously assign . In word , individual previously active rTMS treatment begin sham rTMS treatment vice versa . These session identical involve first treatment phase , except treatment condition different . Before treatment session also ask series question rate potential rTMS side effect complete cognitive task know `` Go/no-go task . ''</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>Patients primary diagnosis OCD ( DSM 5 ) accord MINI YBOCS score â‰¥20 History treatmentresistant OCD , establish trained psychiatrist extensive expertise OCD field . Treatmentresistance define nonresponse least two SRIs trial ( clomipramine , fluoxetine , sertraline , paroxetine , fluvoxamine , citalopram , escitalopram ) . Any additional current psychiatric comorbidity , except mild depressive anxious symptom A lifetime DSM5 diagnosis schizophrenia psychotic syndrome , substance dependence substance abuse , include alcohol , bipolar I II disorder , mental disorder due general medical condition Serious suicide risk Episodic OCD Illness duration less two year Hospitalization last 6 month Pharmacological treatment change last 3 month The inability receive rTMS metallic implant , history seizure ( personal family history seizure first degree relative ) Any major medical disease Pregnancy nursing infant The inability refusal provide inform consent Prior TMS exposure ( order reduce risk unblinding ) . No psychotherapy and/or pharmacological treatment change allow study period . Pharmacologically treated patient constant medication least 2 week enter study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>rTMS</keyword>
	<keyword>treatment refractory</keyword>
	<keyword>treatment resistant</keyword>
	<keyword>SSRI</keyword>
	<keyword>clomipramine</keyword>
</DOC>